PD-1/PD-L1 expression profiles within intrahepatic cholangiocarcinoma predict clinical outcome
Lingyu Tian(Universität Hamburg), Xiaoying Wang(Fudan University), Qiang Gao(Northeastern University), Longzi Liu(Ministry of Education of the People's Republic of China), Bohao Zheng(Fudan University), Zhao Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yining Wang(National Yang Ming Chiao Tung University), Lijie Ma(Shanghai Public Health Clinical Center), Danjun Song(Chinese Academy of Sciences), Kang Song(Fudan University), Jiaqiang Ma(Ministry of Education)
Cited by 58
Related Papers
Lactylome analysis suggests lactylation-dependent mechanisms of metabolic adaptation in hepatocellular carcinoma
|Nature Metabolism|2023|540
PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma
|Journal for ImmunoTherapy of Cancer|2019|387
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
|Nature Communications|2019|297